Skip to main content

Day: May 18, 2021

Eneti Inc. Announces Financial Results for the First Quarter of 2021 and Declares a Quarterly Cash Dividend

MONACO, May 18, 2021 (GLOBE NEWSWIRE) — Eneti Inc. (NYSE: NETI) (“Eneti” or the “Company”), today reported its results for the three months ended March 31, 2021. The Company also announced that on May 14, 2021 its Board of Directors declared a quarterly cash dividend of $0.05 per share on the Company’s common shares. Results for the Three Months Ended March 31, 2021 and 2020For the first quarter of 2021, the Company’s GAAP net income was $41.9 million, or $3.84 per diluted share, including:a gain subsequent to an increase in fair value less costs to sell of approximately $15.5 million, or $1.43 per diluted share, taken related to the Company’s previously announced plan to exit the dry bulk industry. The gain is primarily the result of an increase in the fair value of common shares of Star Bulk Carriers Corp. (“Star Bulk”) (NASDAQ:...

Continue reading

HEXO Corp to Participate in BMO Capital Markets 16th Annual Farm to Market Conference

OTTAWA, May 18, 2021 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that management will participate in BMO Capital Markets 16th Annual Farm to Market Conference. Sebastien St-Louis, Chief Executive Officer, and Trent MacDonald, Chief Financial Officer, will participate in a fireside chat hosted by Tamy Chen, Equity Research Analyst covering cannabis at BMO, on Thursday, May 20, 2021 at 9:20 a.m. ET. Participants may access a live webcast of the fireside chat by going to the “Events” page on hexocorp.com. For more information, please contact your BMO Capital Markets representative. About HEXO Corp (TSX: HEXO; NYSE: HEXO) HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company...

Continue reading

LAVA Therapeutics to Present at 2021 UBS Global Healthcare Virtual Conference

UTRECHT, The Netherlands and PHILADELPHIA, May 18, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced that Stephen Hurly, chief executive officer, will present at the 2021 UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 1:00 p.m. ET. The presentation will be webcast and can be accessed from the investor relations section of the company’s website at www.lavatherapeutics.com. About LAVA LAVA Therapeutics N.V. is a clinical stage biotechnology company developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematological malignancies based on its proprietary platform. The company’s...

Continue reading

Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance

Total consideration is $286 million, reduced by $12 million of working capital to be retained by TeleflexAssets to be divested generated $139M in 2020 revenue, with 2021 growth expected to be approximately flat2021 headwinds are estimated at $28-32 million in revenue and $0.10-$0.15 in adjusted diluted earnings per shareTeleflex is maintaining its current 2021 adjusted diluted earnings per share guidance range WAYNE, Pa., May 18, 2021 (GLOBE NEWSWIRE) — Today, Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced that it has entered into a definitive agreement to sell a significant portion of its Respiratory business to Medline Industries, Inc. (“Medline”) for $286 million in cash, reduced by $12 million in working capital not transferring to Medline. The Teleflex respiratory...

Continue reading

CENTOGENE Appoints Michael Motz as Chief Commercial Officer, Pharmaceuticals

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 18, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the appointment of Dr. Michael Motz as Chief Commercial Officer, Pharmaceuticals, who will join the company on June 1, 2021. Dr. Michael Motz is an entrepreneur and executive with over 25 years of industry experience and has held positions of increasing responsibility in both biotech and pharmaceutical companies during his career. He concluded several large transactions, licensing (in- and out-), and acquisitions with EU and U.S. based life science companies, on both the buy side and the sell side. His experiences have...

Continue reading

Eden Empire Receives Approval in Principle for Flagship Cannabis Retail Store in Vancouver, British Columbia

VANCOUVER, British Columbia, May 18, 2021 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “EDEN™“) is thrilled to announce that it has received its Approval in Principle (“AIP”) from the Liquor & Cannabis Regulation Branch of the Province of British Columbia (the “LRCB”) for a cannabis retail store in Vancouver’s West End. The location will serve as EDEN’s flagship store located at 1674 Davie Street in Vancouver, British Columbia. Receiving AIP from the LRCB is one of the final steps required in licensing a cannabis retail store in the Province of British Columbia. Key TakeawaysLocated in the Lower Davie Village area, this location is considered one of the most densely populated and expanding neighborhoods in Vancouver. Sits just steps away from the bustling Sunset Beach area, a...

Continue reading

Aerial Refueling Systems Market to Reach USD 743.8 Million by 2028; Decision on Commercial Aerial Refueling Services by the US Airforce to Uplift Business: Fortune Business Insights™

Top companies covered are Airbus S.A.S (Netherlands), Cobham Plc (UK), GE Aviation (U.S.), Lockheed Martin Corporation (U.S.), Boeing (The U.S.), Eaton Corporation (The U.S.), Safran S.A. (France), Israel Aerospace Industries (Israel), Marshall Aerospace & Defence Group (The UK), Parker Hannifin (The U.S.), and more players profiled. Pune, India, May 18, 2021 (GLOBE NEWSWIRE) — The global aerial refueling systems market size is expected to reach USD 743.8 million by 2028, exhibiting a CAGR of 4.53% during the forecast period. The increasing development of innovative and lightweight military aircraft such as bombers, fighter jets, and unmanned systems will have a tremendous impact on the market growth during the forecast period, states Fortune Business Insights, in a report, titled “Aerial Refueling Systems Market, 2021-2028.”...

Continue reading

Kronos Advanced Technologies Expands Footprint into India Opening a Marketing Office

Los Angeles, CA, May 18, 2021 (GLOBE NEWSWIRE) — (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), an innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized announced today that the company has opened and will staff an office in Odisha, India. The India office will be a strategic addition to our current offices in the USA and Israel. When the first wave of the corona virus hit India in March 2020, the Indian Government announced a sweeping national lockdown hours before it went into effect, shutting state borders, suspending inter-state travel, halting businesses and requiring people to stay at home. CNN reported today that “calls are growing for another nationwide...

Continue reading

Tattooed Chef Completes Acquisition of New Mexico Food Distributors, Inc. and Karsten Tortilla Factory, LLC; Reclassifies Certain Expenses

Diversifies Manufacturing Capabilities, Expands Production Capacity, and Accelerates Expansion Outside Frozen Food PARAMOUNT, Calif., May 18, 2021 (GLOBE NEWSWIRE) — Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced that on May 14, 2021, it completed the acquisition of New Mexico Food Distributors, Inc. and Karsten Tortilla Factory, LLC (collectively referred to as “Foods of New Mexico”) for approximately $37.0 million in cash, subject to a customary adjustment based on inventory at closing. Foods of New Mexico produces ready-to-eat Mexican food items for both retail and food service. This acquisition diversifies Tattooed Chef’s manufacturing capabilities, expands production capacity, and accelerates the Company’s expansion outside frozen food and into ambient...

Continue reading

Amarin to Present at Two Investor Conferences in June 2021

DUBLIN, Ireland and BRIDGEWATER, N.J., May 18, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that John F. Thero, Amarin’s president and chief executive officer, and Karim Mikhail, Amarin’s senior vice president and head of commercial for Europe and future president and chief executive officer, are scheduled to present at the following investor conferences scheduled in June:Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 9:30 a.m. Eastern Time Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 10:30 a.m. Eastern TimeLive audio webcasts of the presentations will be available at: http://www.amarincorp.com, and will be accessible at the same link for 30 days. About Amarin Amarin is an innovative pharmaceutical company leading a new paradigm...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.